Algen Biotechnologies
ActiveUsing CRISPR to find treatments for cancer and inflammation
This company has previously operated under “Algen Biotechnologies”, “Inc.”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
Founders · 2
Related startups
Discovering the true signals of disease to power life-changing drugs.
We create activating antibodies to treat diseases others can’t.
